Copy Link Print Information

Codrituzumab

(Synonyms: GC33; RO5137382)
1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

Codrituzumab (GC33) is a humanized monoclonal antibody targeting human GPC3 (glypican-3), with high affinity (Kd of 0.673 nM). GPC3 is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth.

For research use only. We do not sell to patients.

  • Purity: 99.07%
  • CAS No.: 1365267-33-9
  • Molecular Weight:145.58 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Codrituzumab
  • Experimental Validation Results for Codrituzumab
  • Experimental Validation Results for Codrituzumab
  • Experimental Validation Results for Codrituzumab
  • Codrituzumab Chemical Structure
    Codrituzumab Chemical Structure
CAS No.: 1365267-33-9
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Codrituzumab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Codrituzumab

More

Keywords

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 kappa

  • 1/16

    Immobilized Glypican-3/GPC3 Protein, Human (HEK293, His, HY-P70487) can bind Codrituzumab. The EC50 for this effect is 13.3 ng/mL.

  • 1/16

    Flow cytometric analysis of 1X106 Jurkat cells with Codrituzumab (HY-P99013, red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Fluor 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa Isotype Control (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • 1/16

    Loaded Codrituzumab on Sensor Chip Protein A, can bind Glypican-3/GPC3 Protein, Human (HEK293, HY-P70487) with an affinity constant of 2.15E-10 M as determined in SPR assay.

  • Codrituzumab Chemical Structure
    1/16
  • Codrituzumab
  • Immobilized Glypican-3/GPC3 Protein, Human (HEK293, His, HY-P70487) can bind Codrituzumab. The EC50 for this effect is 13.3 ng/mL.
  • Flow cytometric analysis of 1X106 Jurkat cells with Codrituzumab (HY-P99013, red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Fluor 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa Isotype Control (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • Loaded Codrituzumab on Sensor Chip Protein A, can bind Glypican-3/GPC3 Protein, Human (HEK293, HY-P70487) with an affinity constant of 2.15E-10 M as determined in SPR assay.